CCLD.NASDAQCarecloud, INC

DEF 14A: CareCloud, Inc. Announces Annual Meeting of Shareholders to be Held on June 17, 2024

Sentiment:

Proxy Statement


CareCloud, Inc. will hold its Annual Meeting of Shareholders on June 17, 2024, to elect directors and vote on executive compensation.

Summary

  • CareCloud, Inc. will hold its Annual Meeting of Shareholders on June 17, 2024, at 11:00 a.m. Eastern Time, at its principal executive offices in Somerset, NJ.
  • Shareholders of record as of April 18, 2024, are entitled to vote.
  • The meeting will include the election of four directors: A. Hadi Chaudhry, John Daly, Mahmud Haq, and Cameron Munter.
  • Shareholders will also vote on an advisory basis on the compensation of the company's named executive officers.
  • The Board of Directors recommends voting FOR the director nominees and FOR the approval of executive compensation.
  • As of April 18, 2024, there were 16,118,492 shares of Common Stock outstanding.
  • The proxy materials were first sent to shareholders on or about May 3, 2024.
  • To be considered, all votes must be received by midnight on June 10, 2024.

Sentiment

Score: 7

Explanation: The document is primarily informational and procedural, with a neutral tone. The presence of related party transactions and a change in auditors slightly lowers the sentiment.

Positives

  • The Board of Directors is actively engaged in overseeing management and ensuring the long-term interests of shareholders are served.
  • The Board has adopted corporate governance principles relating to its role, composition, structure, and functions.
  • The company has a Cybersecurity Subcommittee to assist the Audit Committee in overseeing the Corporation’s information technology systems to identify, assess and manage the risks related to cybersecurity.
  • The company has a Related Person Transaction Policy to ensure that the company's transactions with certain persons are not inconsistent with the best interests of the company.
  • The company has a Code of Conduct to ensure that the company's business is conducted in a consistently legal and ethical manner.

Negatives

  • The company has engaged in several related party transactions, including leasing facilities from the Executive Chairman and sales to a related party.
  • The company has changed independent registered public accounting firms from Grant Thornton LLP to Rosenberg Rich Baker Berman, P.A. (RRBB).

Risks

  • Related person transactions present a heightened risk of conflicts of interest.
  • The company's success depends on its ability to maintain the quality of the Company, including the integrity of the financial statements, the integrity of compliance with laws and ethics, and the integrity of relationships with stakeholders.
  • The company faces strategic, operational, financial, regulatory, and legal risks.

Future Outlook

The Board of Directors will continue to oversee management and ensure the long-term interests of the shareholders are being served.

Management Comments

  • Norman Roth, Interim Chief Financial Officer and Assistant Corporate Secretary: 'It is my pleasure to invite you to attend the Annual Meeting of Shareholders of CareCloud, Inc.'
  • The Board of Directors believes that good corporate governance principles and practices provide a strong framework to assist the Board in fulfilling its responsibilities to shareholders.

Industry Context

This announcement is a standard corporate procedure for publicly traded companies, ensuring shareholders have the opportunity to participate in key decisions regarding the company's governance and direction.

Comparison to Industry Standards

  • The proxy statement follows standard SEC guidelines for disclosing information relevant to shareholder voting.
  • The director compensation structure, including monthly retainers and stock awards, is common among publicly traded companies of similar size and scope.
  • The company's corporate governance practices, such as having independent directors and committees, align with Nasdaq requirements and industry best practices.

Management Changes

RolePrevious PersonNew PersonEffective DateReason
Chief Financial OfficerLawrence SteenvoordenNorman Roth (Interim)January 2024Lawrence Steenvoorden left the Company
General Counsel and Corporate SecretaryNathalie GarciaTBDMarch 2024Nathalie Garcia left the Company

Related Party Transactions

  • The Company had sales to a related party, a physician who is the wife of the Executive Chairman, with revenues of approximately $125,000 and $58,000 for the years ended December 31, 2023 and 2022, respectively.
  • The Company leases its corporate offices in New Jersey, its temporary housing for its foreign visitors, a storage facility, its backup operations center in Bagh, Pakistan and an apartment for temporary housing in Dubai, the UAE, from the Executive Chairman.
  • During June 2022, the Company entered into a one-year consulting agreement with an entity owned and controlled by one of its former non-independent directors whereby that director received shares of the Companys 8.75% Series B Cumulative Redeemable Perpetual Preferred Stock (Series B Preferred Stock) in exchange for assisting the Company to identify and acquire additional companies, including performing due diligence.
  • During 2020, a New Jersey corporation, talkMD Clinicians, PA (talkMD), was formed by the wife of the Executive Chairman, who is a licensed physician, to provide telehealth services.

Stakeholder Impact

  • Shareholders have the opportunity to vote on key decisions regarding the company's governance and executive compensation.
  • Employees are subject to the Company's Code of Conduct and Insider Trading Policy.
  • The company's relationships with customers and suppliers are subject to the Related Person Transaction Policy.

Next Steps

  • Shareholders should review the proxy materials and vote on the proposals.
  • The company will hold the Annual Meeting of Shareholders on June 17, 2024.
  • The company will file a Form 8-K with the SEC to report the final voting results.

Key Dates

DateDescription
April 18, 2024Record date for determining shareholders eligible to vote at the Annual Meeting
May 3, 2024Proxy materials first sent or given to shareholders
June 10, 2024Deadline for submitting votes
June 17, 2024Date of the Annual Meeting of Shareholders

Keywords

Annual Meeting, Proxy Statement, Board of Directors, Shareholders, Executive Compensation, Corporate Governance, Director Election, Related Party Transactions, Audit Committee, Compensation Committee

Disclaimer:The information provided here is for general informational purposes only and does not constitute financial advice, recommendation, or endorsement of any kind. It may contain errors or omissions. You should not rely on this information to make financial decisions. Always seek the advice of a qualified financial professional before making any investment or financial decisions. Use of this information is at your own risk.